NEXT GEN IMMUNOONCOLOGY CONFERENCEUS EDITION

22ND– 23RD JUNE 2023


BOSTON, MA

Event Brief
After our successive IO editions across the globe for the last 7 years, MarketsandMarkets is proud to host the 6th Annual Next Gen Immuno-Oncology Congress

to be held on 22nd-23rd June 2023 in Boston, USA
The conference would address the novel case-studies and developments in IO research across the 2 days aiming to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This meeting would also focus on various combination strategies, pre-clinical and translational immuneoncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.
For more information please contact

Monoclonal and Bispecific Antibodies
• ADCs development Preclinical and Translational Oncology
• Oncology
• Bi-specifics- Preclinical and Translational
• Clinical development
• R&D- Discovery and process
• PKPD/ADME/Tox
• Antibody Engineering
• Antibody therapeutics
• Physio-Chemistry / Synthetic Chemistry and/ Bio conjugation
• Bioanalysis
Who should Attend?
Academics: University/ Research Institutes/Research Labs
Industry:
Pharma / Biopharma (Therapeutic Companies)

From Pharmaceutical, Biopharmaceutical and Research Institutes:
CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows, PhDs working on

Cell Therapy
• Oncology
• Clinical development
• T cell therapy
• CAR-T cell therapy
• R&D- discovery and process
• Therapeutic areas
• PKPD/ADME/Tox
• Biologics -antibody
• Cell-Based Immunotherapies
• Innate and adaptive immune cells
• Antibody engineering
• Tumour antigens and neoantigens
Immune Checkpoint Inhibitors
• Cancer immunotherapy
• Immune checkpoint targets
• Checkpoint inhibition
• Cellular therapy
• Clinical research
• Combination therapy
• Cancer Vaccines
• Preclinical and Translational Oncology R&D
• Immune biomarkers
• Immunology
• Cancer biology
• Immuno-oncology
• Tumour-associated mechanisms of immune suppression















SPEAKER LIST





About MarketsandMarkets


MarketsandMarkets Events is a wholly owned division of MarketsandMarkets a global market research and intelligence company producing over 1200 premium market research reports every year across 12 different industry verticals. By bringing together expert speakers from across the world and leading technology and service providers Events provide a senior level educational and networking platform where knowledge is shared and partnerships and collaborations can be formed. With offices in Asia Europe and USA MarketsandMarkets ensures a truly global attendance at every event where attendees speakers exhibitors and sponsors can exchange ideas in a relaxed and professional environment.
+91 20 48598 285 | +44 (0)1865-842-976 events@marketsandmarkets.com
www.marketsandmarkets.com